Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
gene therapy
life sciences
novartis
spinal muscular atrophy
zolgensma
2
×
adaptive biotechnologies
alicrocumab
american academy of neu
american academy of neurology
bicycle therapeutics
biogen
bioinnovation capital
biolabs
biopharma
board of directors
boston
boston top stories
bostongene
boulder/denver blog main
boulder/denver top stories
canaan partners
chemotherapy
clinical trials
contepo
daraprim
data
dementia
democrats
detroit blog main
detroit top stories
drug pricing
drugs
eisai
epipen
epipens
exome
fbi raid
fda
What
healthcare
2
×
public
america
bio
biogen
biotech
continues
convoluted
democrats
dreams
driving
drug
good
head
headaches
history
holding
improved
industry
innovation
innovations
insurance
investment
ipo
life
long
medical
moves
outcomes
previews
pricing
private
proud
roundup
sciences
scrutiny
spine
suffer
week
wide
Language
unset
Current search:
zolgensma
×
healthcare
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More